First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours

British Journal of Cancer, Published online: 29 September 2020; doi:10.1038/s41416-020-01077-zFirst-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours

Source: British Journal of Cancer - September 28, 2020 Category: Cancer & Oncology Authors: Malaka Ameratunga Irene Bra ña Petri Bono Sophie Postel-Vinay Ruth Plummer John Aspegren Timo Korjamo Amir Snapir Johann S de Bono Source Type: research